In the world of childhood cancer research, the St. Baldrick’s Foundation and the Children’s Oncology Group (COG) are two superheroes, teaming up to use their complementary strengths to save lives.
Dr. Mary Lou Schmidt decorates pumpkins with her patient, Isaac, and his mom. Isaac is on a Children’s Oncology Group clinical trial that’s part of a unique tri-institutional clinical trial program in Chicago that’s supported by St. Baldrick’s.
When Honored Kid Will was 3 years old, he was diagnosed with cancer. Now, the third grader with the dimpled smile and bright eyes is healthy, thanks to a clinical trial made possible by St. Baldrick’s funding. Read on for Will’s story of survival.
NEW VIDEO: Will’s Story >
On the surface, Will looks like any other 8-year-old boy. He loves playing soccer, camping with his family, and playing with their dog, Jack. The third grader is a big fan of superheroes and is also quite the successful fisherman.
You’d never guess that most of his young life has been spent fighting cancer.
Thanks to nearly a decade of St. Baldrick’s infrastructure grants, all kids treated at three of Chicago’s largest hospitals are getting access to the clinical trials they desperately need. Read on to see how this program YOU made possible is helping find cures for kids with cancer everywhere.
Dr. Mary Lou Schmidt decorates pumpkins with her patient, Isaac, and his mom. Isaac is on a clinical trial that’s part of a unique tri-institutional clinical trial program supported by St. Baldrick’s.
Clinical trials can be options for kids with cancer who have no options left. They can mean better chances at long, healthy lives with fewer side effects. They are hope for a cure for kids with cancer today, and for kids in the future.
We have some big news that will have you jumping through the sprinkler with joy.
Summer has arrived and so have St. Baldrick’s Summer Grants!
Today we are awarding a whopping $21.2 million in new research grants to scientists across the globe. That’s 70 grants in 48 states and 11 countries, going to researchers making incredible gains in the fight against childhood cancer.
When the Vannie E. Cook Jr. Children’s Cancer and Hematology Clinic opened in the border town of McAllen, Texas, it offered care that otherwise would have been out of reach for many kids with cancer in the area. Today its young patients have the opportunity to participate in cutting edge research — the clinic, with the support of St. Baldrick’s grants, was accepted into the Children’s Oncology Group, or COG, and is now conducting COG clinical trials.
Alma, a nurse at the Vannie Cook clinic in McAllen, Texas, laughs with Leidy, a patient there who has now finished treatment.
We’ve got some spectacular news. Really, really big news.
In the last 20 years, only two new drugs have been approved that were specifically developed to treat children with cancer.
Yesterday, that changed. Now there are three.
An inside look at what St. Baldrick’s Infrastructure Grants are really doing. See all the 2014 Fall Grants.
Kelly Clickner assists a patient enrolled in a clinical trial at Albany Medical Center. They were able to hire Kelly as a full-time CRA with their first St. Baldrick’s Infrastructure Grant in 2007.
The Children’s Oncology Group, or COG, has done some pretty awesome things to change the face of childhood cancer. The St. Baldrick’s Foundation has granted over $46 million to the COG so that kids with cancer can get the cures they need.
It’s been said that the Children’s Oncology Group, or COG, is arguably the National Cancer Institute’s best success story. The COG’s clinical trials have increased the overall cure rate for childhood cancers from under 10% 50 years ago to over 80% today.
This is a road to success, but there are many miles to go before every child can be cured.
Why are there so few drugs available to fight childhood cancers? Why have no new drugs been developed and approved specifically for pediatric cancers in decades?
These questions dominated the agenda on February 21 when the National Cancer Institute (NCI) convened the 64th meeting of its Director’s Consumer Liaison Group in Bethesda, Maryland. Entitled “Barriers to Drug Development in Pediatric Cancer Research,” the all-day meeting included presentations from oncologists, government scientists, physicians, and members of the childhood cancer advocacy community.
The St. Baldrick’s Foundation is proud to have been honored at today’s meeting of many of the world’s best and brightest minds in pediatric cancer research.
The Children’s Oncology Group (COG), the world’s largest organization devoted exclusively to childhood and adolescent cancer research, thanked St. Baldrick’s at their annual fall meeting today for granting more than $46 million to date in support of the COG’s efforts to find cures and better treatments for all children with cancer.
Older Posts »